In recent researches about MM therapies, STAT3 was found highly expressed in many CD138 positive cells isolated from primary MM patients, and its expression is often associated with MM pathogenesis and its chemo-resistance to most of the clinical therapies [4, 5]. Here, SDC1 is linked to Miyoshi myopathy.